| A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. TR Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU ... N Engl J Med. 19 (361(21)), 2019-32, 2009 | 1646* | 2009 |
| Tolvaptan in patients with autosomal dominant polycystic kidney disease CFS Torres VE, Chapman AB, Devuyst O, Gansevoort RT, ... N Engl J Med 367 (25), 2407-2418, 2012 | 793* | 2012 |
| Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis PPSCG EVOLVE Trial Investigators, Chertow GM, Block GA New Engl J Med 367 (26), 2482-2494, 2012 | 603 | 2012 |
| Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy F Lang, K Klingel, CA Wagner, C Stegen, S Wärntges, B Friedrich, ... Proceedings of the National Academy of Sciences 97 (14), 8157-8162, 2000 | 264 | 2000 |
| Recommendations for biomarker identification and qualification in clinical proteomics H Mischak, G Allmaier, R Apweiler, T Attwood, M Baumann, A Benigni, ... Science translational medicine 2 (46), 46ps42-46ps42, 2010 | 228 | 2010 |
| Pharmacokinetics and metabolism of hydroxytyrosol, a natural antioxidant from olive oil S D'Angelo, C Manna, V Migliardi, O Mazzoni, P Morrica, G Capasso, ... Drug Metabolism and Disposition 29 (11), 1492-1498, 2001 | 210 | 2001 |
| Coupling between proximal tubular transport processes KJ Ullrich, G Capasso, G Rumrich, F Papavassiliou, S Klöss Pflügers Archiv 368 (3), 245-252, 1977 | 158 | 1977 |
| Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine. AF Pema, D Ingrosso, V Zappia, P Galletti, G Capasso, NG De Santo The Journal of clinical investigation 91 (6), 2497-2503, 1993 | 127 | 1993 |
| Renal tubular acidosis: developments in our understanding of the molecular basis CM Laing, AM Toye, G Capasso, RJ Unwin The international journal of biochemistry & cell biology 37 (6), 1151-1161, 2005 | 120 | 2005 |
| Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney … RT Gansevoort, M Arici, T Benzing, H Birn, G Capasso, A Covic, ... Nephrology Dialysis Transplantation 31 (3), 337-348, 2016 | 98 | 2016 |
| Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome P Ruggenenti, B Ruggiero, P Cravedi, M Vivarelli, L Massella, M Marasà, ... Journal of the American Society of Nephrology 25 (4), 850-863, 2014 | 96 | 2014 |
| Population based data on urinary excretion of calcium, magnesium, oxatate, phosphate and uric acid in children from Cimitile (southern Italy) NG De Santo, B Di Iorio, G Capasso, C Paduano, R Stamler, ... Pediatric Nephrology 6 (2), 149-157, 1992 | 92 | 1992 |
| A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. PG Raj DA, Fiume I, Capasso G KIDNEY INTERNATIONAL, 2012 | 81 | 2012 |
| Regulation of CLC-Ka/barttin by the ubiquitin ligase Nedd4-2 and the serum-and glucocorticoid-dependent kinases HM Embark, C Böhmer, M Palmada, J Rajamanickam, AW Wyatt, ... Kidney international 66 (5), 1918-1925, 2004 | 77 | 2004 |
| Effects of thyroid hormones on heart and kidney functions G Capasso, G De Tommaso, A Pica, P Anastasio, J Capasso, R Kinne, ... Mineral and electrolyte metabolism 25 (1-2), 56-64, 1999 | 75 | 1999 |
| Renal bicarbonate reabsorption in the rat. II. Distal tubule load dependence and effect of hypokalemia. G Capasso, P Jaeger, G Giebisch, V Guckian, G Malnic The Journal of clinical investigation 80 (2), 409-414, 1987 | 69 | 1987 |
| In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats G Capasso, CI Di Gennaro, FD Ragione, C Manna, R Ciarcia, S Florio, ... Nephrology Dialysis Transplantation 23 (4), 1186-1195, 2007 | 66 | 2007 |
| Renal bicarbonate reabsorption in the rat. I. Effects of hypokalemia and carbonic anhydrase. G Capasso, R Kinne, G Malnic, G Giebisch The Journal of clinical investigation 78 (6), 1558-1567, 1986 | 65 | 1986 |
| Risk factors for poor renal prognosis in children with hemolytic uremic syndrome A Gianviti, AE Tozzi, L De Petris, A Caprioli, L Ravà, A Edefonti, ... Pediatric Nephrology 18 (12), 1229-1235, 2003 | 60 | 2003 |
| Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease. SO Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G ... N Engl J Med. 16 (377), 1930-1942, 2017 | 58* | 2017 |
anastasio pietroricercatore seconda università di NapoliVerified email at unina2.it